421 related articles for article (PubMed ID: 30701324)
1. Particle Surface Roughness Improves Colloidal Stability of Pressurized Pharmaceutical Suspensions.
Wang H; Nobes DS; Vehring R
Pharm Res; 2019 Jan; 36(3):43. PubMed ID: 30701324
[TBL] [Abstract][Full Text] [Related]
2. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
D'Sa D; Chan HK
Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the suspension stability of pharmaceuticals using a shadowgraphic imaging method.
Wang H; Tan P; Barona D; Li G; Hoe S; Lechuga-Ballesteros D; Nobes DS; Vehring R
Int J Pharm; 2018 Sep; 548(1):128-138. PubMed ID: 29959088
[TBL] [Abstract][Full Text] [Related]
5. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
6. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
7. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
D'Sa D; Chan HK; Chrzanowski W
Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
[TBL] [Abstract][Full Text] [Related]
8. Trileucine improves aerosol performance and stability of spray-dried powders for inhalation.
Lechuga-Ballesteros D; Charan C; Stults CL; Stevenson CL; Miller DP; Vehring R; Tep V; Kuo MC
J Pharm Sci; 2008 Jan; 97(1):287-302. PubMed ID: 17823950
[TBL] [Abstract][Full Text] [Related]
9. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
Wu L; Al-Haydari M; da Rocha SR
Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
[TBL] [Abstract][Full Text] [Related]
10. Trileucine as a dispersibility enhancer of spray-dried inhalable microparticles.
Ordoubadi M; Gregson FKA; Wang H; Carrigy NB; Nicholas M; Gracin S; Lechuga-Ballesteros D; Reid JP; Finlay WH; Vehring R
J Control Release; 2021 Aug; 336():522-536. PubMed ID: 34229002
[TBL] [Abstract][Full Text] [Related]
11. Amorphous pullulan trehalose microparticle platform for respiratory delivery.
Carrigy NB; Ordoubadi M; Liu Y; Melhem O; Barona D; Wang H; Milburn L; Ruzycki CA; Finlay WH; Vehring R
Int J Pharm; 2019 May; 563():156-168. PubMed ID: 30951858
[TBL] [Abstract][Full Text] [Related]
12. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
Pu Y; Kline LC; Berry J
Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
[TBL] [Abstract][Full Text] [Related]
13. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
Selvam P; El-Sherbiny IM; Smyth HD
J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
[TBL] [Abstract][Full Text] [Related]
14. Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development.
Czyz S; Wewers M; Finke JH; Kwade A; van Eerdenbrugh B; Juhnke M; Bunjes H
Eur J Pharm Biopharm; 2020 Jul; 152():63-71. PubMed ID: 32376369
[TBL] [Abstract][Full Text] [Related]
15. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
[TBL] [Abstract][Full Text] [Related]
16. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
[TBL] [Abstract][Full Text] [Related]
17. Novel pMDI formulations for pulmonary delivery of proteins.
Li HY; Seville PC
Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
[TBL] [Abstract][Full Text] [Related]
18. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
19. Formation of protein nano-matrix particles with controlled surface architecture for respiratory drug delivery.
Kwok PC; Tunsirikongkon A; Glover W; Chan HK
Pharm Res; 2011 Apr; 28(4):788-96. PubMed ID: 21136142
[TBL] [Abstract][Full Text] [Related]
20. Anhydrous reverse micelle nanoparticles: new strategy to overcome sedimentation instability of peptide-containing pressurized metered-dose inhalers.
Huang Z; Wu H; Yang B; Chen L; Huang Y; Quan G; Zhu C; Li X; Pan X; Wu C
Drug Deliv; 2017 Nov; 24(1):527-538. PubMed ID: 28181839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
